Breast Cancer Diagnostic and Drug Technologies Market Report

Global and Region Breast Cancer Diagnostic and Drug Technologies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：211
  • REPORT CODE：GMM994467
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Breast Cancer Diagnostic and Drug Technologies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Breast Cancer Diagnostic and Drug Technologiesmarket, defines the market attractiveness level of Breast Cancer Diagnostic and Drug Technologies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Breast Cancer Diagnostic and Drug Technologies industry, describes the types of Breast Cancer Diagnostic and Drug Technologies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Breast Cancer Diagnostic and Drug Technologies market and the development prospects and opportunities of Breast Cancer Diagnostic and Drug Technologies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Breast Cancer Diagnostic and Drug Technologies market in Chapter 13.

    By Player:

    • Roche

    • Hologic

    • Abbott

    • PerkinElmer

    • Philips

    • Quest Diagnostics

    • GE Healthcare

    • BioMerieux

    • Becton Dickinson

    By Type:

    • Mammography

    • Biopsy

    • Other

    By End-User:

    • Ductal Carcinoma of Breast

    • Invasive Ductal Carcinoma

    • Lobular Carcinoma

    • Triple Negative Breast Cancer

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Breast Cancer Diagnostic and Drug Technologies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Breast Cancer Diagnostic and Drug Technologies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Breast Cancer Diagnostic and Drug Technologies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Breast Cancer Diagnostic and Drug Technologies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Breast Cancer Diagnostic and Drug Technologies Market Analysis and Outlook to 2022

    • 7.1 Global Breast Cancer Diagnostic and Drug Technologies Consumption (2017-2022)

    • 7.2 United States Breast Cancer Diagnostic and Drug Technologies Consumption (2017-2022)

    • 7.3 Europe Breast Cancer Diagnostic and Drug Technologies Consumption (2017-2022)

    • 7.4 China Breast Cancer Diagnostic and Drug Technologies Consumption (2017-2022)

    • 7.5 Japan Breast Cancer Diagnostic and Drug Technologies Consumption (2017-2022)

    • 7.6 India Breast Cancer Diagnostic and Drug Technologies Consumption (2017-2022)

    • 7.7 South Korea Breast Cancer Diagnostic and Drug Technologies Consumption (2017-2022)

    8 Region and Country-wise Breast Cancer Diagnostic and Drug Technologies Market Analysis and Outlook to 2028

    • 8.1 Global Breast Cancer Diagnostic and Drug Technologies Consumption Forecast (2022-2028)

    • 8.2 United States Breast Cancer Diagnostic and Drug Technologies Consumption Forecast (2022-2028)

    • 8.3 Europe Breast Cancer Diagnostic and Drug Technologies Consumption Forecast (2022-2028)

    • 8.4 China Breast Cancer Diagnostic and Drug Technologies Consumption Forecast (2022-2028)

    • 8.5 Japan Breast Cancer Diagnostic and Drug Technologies Consumption Forecast (2022-2028)

    • 8.6 India Breast Cancer Diagnostic and Drug Technologies Consumption Forecast (2022-2028)

    • 8.7 South Korea Breast Cancer Diagnostic and Drug Technologies Consumption Forecast (2022-2028)

    9 Global Breast Cancer Diagnostic and Drug Technologies Market Outlook by Types and Applications to 2022

    • 9.1 Global Breast Cancer Diagnostic and Drug Technologies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mammography Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Biopsy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Breast Cancer Diagnostic and Drug Technologies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Ductal Carcinoma of Breast Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Invasive Ductal Carcinoma Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Lobular Carcinoma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Triple Negative Breast Cancer Consumption and Growth Rate (2017-2022)

    10 Global Breast Cancer Diagnostic and Drug Technologies Market Outlook by Types and Applications to 2028

    • 10.1 Global Breast Cancer Diagnostic and Drug Technologies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Mammography Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Biopsy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Breast Cancer Diagnostic and Drug Technologies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Ductal Carcinoma of Breast Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Invasive Ductal Carcinoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Lobular Carcinoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Triple Negative Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    11 Global Breast Cancer Diagnostic and Drug Technologies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Breast Cancer Diagnostic and Drug Technologies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Breast Cancer Diagnostic and Drug Technologies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Breast Cancer Diagnostic and Drug Technologies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Breast Cancer Diagnostic and Drug Technologies Market Competitive Analysis

    • 14.1 Roche

      • 14.1.1 Roche Company Details

      • 14.1.2 Roche Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Roche Breast Cancer Diagnostic and Drug Technologies Product and Service

    • 14.2 Hologic

      • 14.2.1 Hologic Company Details

      • 14.2.2 Hologic Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Hologic Breast Cancer Diagnostic and Drug Technologies Product and Service

    • 14.3 Abbott

      • 14.3.1 Abbott Company Details

      • 14.3.2 Abbott Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Abbott Breast Cancer Diagnostic and Drug Technologies Product and Service

    • 14.4 PerkinElmer

      • 14.4.1 PerkinElmer Company Details

      • 14.4.2 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product and Service

    • 14.5 Philips

      • 14.5.1 Philips Company Details

      • 14.5.2 Philips Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Philips Breast Cancer Diagnostic and Drug Technologies Product and Service

    • 14.6 Quest Diagnostics

      • 14.6.1 Quest Diagnostics Company Details

      • 14.6.2 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product and Service

    • 14.7 GE Healthcare

      • 14.7.1 GE Healthcare Company Details

      • 14.7.2 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product and Service

    • 14.8 BioMerieux

      • 14.8.1 BioMerieux Company Details

      • 14.8.2 BioMerieux Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Product and Service

    • 14.9 Becton Dickinson

      • 14.9.1 Becton Dickinson Company Details

      • 14.9.2 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Breast Cancer Diagnostic and Drug Technologies

    • Figure Breast Cancer Diagnostic and Drug Technologies Picture

    • Table Global Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Breast Cancer Diagnostic and Drug Technologies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Breast Cancer Diagnostic and Drug Technologies Consumption by Country (2017-2022)

    • Figure United States Breast Cancer Diagnostic and Drug Technologies Consumption and Growth Rate (2017-2022)

    • Table Europe Breast Cancer Diagnostic and Drug Technologies Consumption and Growth Rate (2017-2022)

    • Figure China Breast Cancer Diagnostic and Drug Technologies Consumption and Growth Rate (2017-2022)

    • Figure Japan Breast Cancer Diagnostic and Drug Technologies Consumption and Growth Rate (2017-2022)

    • Figure India Breast Cancer Diagnostic and Drug Technologies Consumption and Growth Rate (2017-2022)

    • Figure South Korea Breast Cancer Diagnostic and Drug Technologies Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Diagnostic and Drug Technologies Consumption Forecast by Country (2022-2028)

    • Figure United States Breast Cancer Diagnostic and Drug Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Breast Cancer Diagnostic and Drug Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Breast Cancer Diagnostic and Drug Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Breast Cancer Diagnostic and Drug Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Breast Cancer Diagnostic and Drug Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Breast Cancer Diagnostic and Drug Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mammography Consumption and Growth Rate (2017-2022)

    • Figure Global Biopsy Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Ductal Carcinoma of Breast Consumption and Growth Rate (2017-2022)

    • Figure Global Invasive Ductal Carcinoma Consumption and Growth Rate (2017-2022)

    • Figure Global Lobular Carcinoma Consumption and Growth Rate (2017-2022)

    • Figure Global Triple Negative Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Mammography Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ductal Carcinoma of Breast Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Invasive Ductal Carcinoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lobular Carcinoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Triple Negative Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Breast Cancer Diagnostic and Drug Technologies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Breast Cancer Diagnostic and Drug Technologies Export by Region (Top 5 Countries) (2017-2028)

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Breast Cancer Diagnostic and Drug Technologies Product and Service

    • Table Hologic (Foundation Year, Company Profile and etc.)

    • Table Hologic Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic Breast Cancer Diagnostic and Drug Technologies Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Breast Cancer Diagnostic and Drug Technologies Product and Service

    • Table PerkinElmer (Foundation Year, Company Profile and etc.)

    • Table PerkinElmer Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product and Service

    • Table Philips (Foundation Year, Company Profile and etc.)

    • Table Philips Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Philips Breast Cancer Diagnostic and Drug Technologies Product and Service

    • Table Quest Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product and Service

    • Table BioMerieux (Foundation Year, Company Profile and etc.)

    • Table BioMerieux Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMerieux Breast Cancer Diagnostic and Drug Technologies Product and Service

    • Table Becton Dickinson (Foundation Year, Company Profile and etc.)

    • Table Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US